4/26/2012

Sixty-five percent of patients in a community setting had a misdiagnosis or inconclusive data after an FDG-PET scan for Alzheimer's disease, with 35% having false-positive results, according to a study presented at a neurology meeting. The study indicates a need to standardize protocols for reading results, an expert said. Another expert has expressed concern over the findings, particularly with the arrival of new PET tracers for Alzheimer's.

Related Summaries